Need professional-grade analysis? Visit stockanalysis.com
$27.92M
N/A
N/A
N/A
Longeveron LLC (LGVN) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.98, down 5.20% from the previous close.
Over the past year, LGVN has traded between a low of $0.48 and a high of $1.74. The stock has lost 40.8% over this period. It is currently 43.9% below its 52-week high.
Longeveron LLC has a market capitalization of $27.92M.
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Side-by-side comparison against top Healthcare peers.